|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4190328A
(en)
|
1978-12-01 |
1980-02-26 |
Levine Robert A |
Process for detection of blood-borne parasites
|
|
DE2928477C3
(de)
*
|
1979-07-14 |
1982-04-15 |
Battelle-Institut E.V., 6000 Frankfurt |
Vorrichtung zur Freisetzung von Substanzen an definierten Orten des Verdauungstraktes
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
AU636110B2
(en)
|
1988-06-08 |
1993-04-22 |
Nichols Institute Diagnostics |
Assays utilizing sensitizer-induced production of detectable signal
|
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
|
US5314805A
(en)
|
1991-10-28 |
1994-05-24 |
Molecular Probes, Inc. |
Dual-fluorescence cell viability assay using ethidium homodimer and calcein AM
|
|
US5596090A
(en)
|
1992-07-24 |
1997-01-21 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human VCAM-1 RNA
|
|
AU701578B2
(en)
|
1992-08-21 |
1999-02-04 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US5763602A
(en)
|
1996-10-01 |
1998-06-09 |
Li; Ying-Syi |
Methods of syntheses of phthalocyanine compounds
|
|
US5919792A
(en)
|
1996-10-30 |
1999-07-06 |
Merck & Co., Inc. |
Integrin antagonists
|
|
WO1998043962A1
(en)
|
1997-03-28 |
1998-10-08 |
Du Pont Pharmaceuticals Company |
Heterocyclic integrin inhibitor prodrugs
|
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
|
ES2306482T3
(es)
|
1997-08-28 |
2008-11-01 |
Novartis Ag |
Antagonistas de antigeno-1 funcion con funcion de linfocito.
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AU2679899A
(en)
|
1998-02-18 |
1999-09-06 |
Dade Behring Inc. |
Chemiluminescent compositions for use in detection of multiple analytes
|
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
PL350050A1
(en)
|
1999-01-22 |
2002-10-21 |
Elan Pharm Inc |
Acyl derivatives which treat vla-4 related disorders
|
|
US8636648B2
(en)
*
|
1999-03-01 |
2014-01-28 |
West View Research, Llc |
Endoscopic smart probe
|
|
US6331530B1
(en)
|
1999-07-13 |
2001-12-18 |
The Trustees Of Columbia University In The City Of New York |
Hydrophilic carrier for photosensitizers that cleaves when they catalyze the formation of singlet oxygen
|
|
US6703248B1
(en)
|
1999-12-15 |
2004-03-09 |
Dade Behring Marburg Gmbh |
Particles for diagnostic and therapeutic use
|
|
WO2001056607A1
(en)
|
2000-02-03 |
2001-08-09 |
Eisai Co., Ltd. |
Integrin expression inhibitors
|
|
CA2400040A1
(en)
|
2000-02-25 |
2001-08-30 |
Immunex Corporation |
Integrin antagonists
|
|
AU2001262089A1
(en)
|
2000-03-14 |
2001-09-24 |
Novartis Ag |
Alpha4beta1 and alpha4beta7 integrin inhibitors
|
|
US6794506B2
(en)
|
2000-07-21 |
2004-09-21 |
Elan Pharmaceuticals, Inc. |
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
|
|
DE10040105A1
(de)
|
2000-08-17 |
2002-02-28 |
Merck Patent Gmbh |
Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften
|
|
EP1359845B1
(en)
*
|
2001-01-22 |
2012-11-14 |
Spectrum Dynamics LLC |
Ingestible device
|
|
US7160258B2
(en)
*
|
2001-06-26 |
2007-01-09 |
Entrack, Inc. |
Capsule and method for treating or diagnosing the intestinal tract
|
|
DE10204789A1
(de)
|
2002-02-06 |
2003-08-14 |
Merck Patent Gmbh |
Inhibitoren des Integrins alpha¶v¶beta6
|
|
US6949347B2
(en)
|
2002-03-05 |
2005-09-27 |
Aclara Biosciences, Inc. |
Multiplex analysis using membrane-bound sensitizers
|
|
CN1646160A
(zh)
|
2002-03-13 |
2005-07-27 |
拜奥根Idec马萨诸塞公司 |
抗αvβ6抗体
|
|
DE60334378D1
(de)
*
|
2002-07-05 |
2010-11-11 |
Temrel Ltd |
Zusammensetzung zur kontrollierten wirkstoffabgabe
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
AU2004208580A1
(en)
*
|
2003-01-29 |
2004-08-12 |
E-Pill Pharma Ltd. |
Active drug delivery in the gastrointestinal tract
|
|
DE10305784A1
(de)
|
2003-02-12 |
2004-08-26 |
Merck Patent Gmbh |
Verfahren zur Herstellug bicyclischer aromatischer Aminosäuren sowie deren Zwischenprodukte
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
|
US7402398B2
(en)
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
|
AU2004275804A1
(en)
|
2003-09-23 |
2005-04-07 |
Light Sciences Oncology, Inc. |
Conjugates for photodynamic therapy
|
|
EP1667668B1
(en)
|
2003-10-01 |
2008-07-02 |
MERCK PATENT GmbH |
Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
|
|
EP1677783A2
(en)
|
2003-10-08 |
2006-07-12 |
Nicholas Piramal India Limited |
Fibrinogen receptor antagonists and their use
|
|
AU2004287875B2
(en)
|
2003-11-05 |
2011-06-02 |
Bausch + Lomb Ireland Limited |
Modulators of cellular adhesion
|
|
DE602005021475D1
(de)
*
|
2004-03-26 |
2010-07-08 |
Lek Pharmaceuticals |
Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
|
|
EP1778726A4
(en)
|
2004-08-16 |
2009-03-18 |
Medimmune Inc |
INTEGRIN ANTAGONISTS WITH IMPROVED ANTIBODY-DEPENDENT CELL-ASSAYED CYTOTOXICITY ACTIVITY
|
|
DK176145B1
(da)
|
2004-09-23 |
2006-10-02 |
Guldmann V As |
Kobling
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
DE102004059613A1
(de)
*
|
2004-12-10 |
2006-06-14 |
Liedtke, Rainer K., Dr. |
Zusammensetzung und Methode einer topischen Therapie von Neurodermitis
|
|
JP2008532568A
(ja)
*
|
2005-01-18 |
2008-08-21 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
電子制御されるカプセル
|
|
ITMI20050328A1
(it)
|
2005-03-03 |
2006-09-04 |
Univ Degli Studi Milano |
Composti peptidomimetrici e preparazione di derivati biologicamente attivi
|
|
GB0507918D0
(en)
|
2005-04-19 |
2005-05-25 |
Novartis Ag |
Organic compounds
|
|
US8030328B2
(en)
|
2005-05-20 |
2011-10-04 |
Elan Pharmaceuticals, Inc. |
Imidazolone phenylalanine derivatives
|
|
KR20130108481A
(ko)
|
2005-08-19 |
2013-10-02 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
GB0520378D0
(en)
|
2005-10-06 |
2005-11-16 |
Novartis Ag |
Organic compounds
|
|
EP2298308B1
(en)
|
2005-11-14 |
2013-01-16 |
University Of Southern California |
Integrin-binding small molecules
|
|
EP1951665A1
(en)
|
2005-11-14 |
2008-08-06 |
Dominion Pharmakine S.L. |
Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof
|
|
EP1961750B1
(en)
|
2005-12-13 |
2013-09-18 |
Daiichi Sankyo Company, Limited |
Vla-4 inhibitory drug
|
|
WO2007101165A1
(en)
|
2006-02-27 |
2007-09-07 |
Elan Pharmaceuticals, Inc. |
Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
HRP20150884T1
(hr)
|
2006-03-21 |
2015-09-25 |
Genentech, Inc. |
Kombinacijska terapija koja ukljuäśuje antagoniste alfa5beta1
|
|
JP2009536641A
(ja)
|
2006-05-31 |
2009-10-15 |
ハンワ ケミカル コーポレイション |
Ｖｃａｍ−１特異的モノクローナル抗体
|
|
JP2009541018A
(ja)
*
|
2006-06-23 |
2009-11-26 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
薬剤投与システム
|
|
TW200815474A
(en)
|
2006-08-03 |
2008-04-01 |
Astrazeneca Ab |
Antibodies alphaVbeta6 and uses thereof
|
|
EP2125076B1
(en)
*
|
2007-02-26 |
2012-06-20 |
Duocure, Inc. |
Spray administration of compositions including active agents such as peptides to the gastrointestinal tract
|
|
EP2079456B1
(en)
*
|
2007-04-04 |
2012-12-05 |
Sigmoid Pharma Limited |
Pharmaceutical cyclosporin compositions
|
|
DK2167128T3
(da)
|
2007-07-17 |
2012-12-03 |
Merck Patent Gmbh |
Fremstillede anti-alfa-v-integrin hybrid-antistoffer
|
|
WO2009076434A1
(en)
|
2007-12-12 |
2009-06-18 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of integrin vla-4
|
|
WO2011004395A1
(en)
|
2009-07-06 |
2011-01-13 |
Intas Biopharmaceuticals Limited |
Microemulsion formulation for biologicals
|
|
JP6030956B2
(ja)
*
|
2009-08-05 |
2016-11-24 |
テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド |
胃腸管の異常の診断に使える情報を提供する方法と機器
|
|
WO2011049412A2
(en)
|
2009-10-23 |
2011-04-28 |
Hanwha Chemical Corporation |
Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
|
|
ITFI20100019A1
(it)
|
2010-02-12 |
2011-08-13 |
Univ Firenze |
Inibitori peptidomimetici di integrine basati sull'1,2,3-triazolo per la diagnosi e terapia dei tumori.
|
|
CA2793838C
(en)
|
2010-03-19 |
2019-09-17 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Integrin interaction inhibitors for the treatment of cancer
|
|
CA2797974A1
(en)
|
2010-04-30 |
2011-11-03 |
Elan Pharmaceuticals, Inc. |
Selective integrin inhibitors
|
|
US9415004B2
(en)
*
|
2010-12-23 |
2016-08-16 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
|
US8907081B2
(en)
|
2011-05-27 |
2014-12-09 |
Sharp Laboratories Of America, Inc. |
Long wavelength absorbing porphyrin photosensitizers for dye-sensitized solar cells
|
|
PL2744802T3
(pl)
|
2011-08-17 |
2017-07-31 |
Piramal Imaging Sa |
Związki do wiązania do glikoproteiny IIB/IIIA specyficznej wobec płytek i ich zastosowanie do obrazowania zakrzepów
|
|
FR2979346B1
(fr)
|
2011-08-23 |
2013-09-27 |
Univ Joseph Fourier |
Nanocorps anti-vcam-1
|
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
|
FR2986432B1
(fr)
|
2012-02-06 |
2014-03-14 |
Univ Lille Ii Droit & Sante |
Proteines 28kda gst provenant de schistosomes pour leur utilisation dans le traitement des maladies inflammatoires auto-immunes engendrant une reponse de type th1 et/ou th17
|
|
GB201207155D0
(en)
|
2012-04-24 |
2012-06-06 |
Isis Innovation |
Antibodies
|
|
US20140349944A1
(en)
|
2013-05-23 |
2014-11-27 |
Musc Foundation For Research Development |
Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases
|
|
SG11201509371XA
(en)
|
2013-05-24 |
2015-12-30 |
Nestec Sa |
Pathway specific markers for diagnosing irritable bowel syndrome
|
|
ES2950424T3
(es)
*
|
2013-07-03 |
2023-10-09 |
Takeda Pharmaceuticals Co |
Compuesto de amida
|
|
EP3750590B8
(en)
*
|
2013-09-26 |
2025-08-13 |
BT Bidco, Inc. |
Delivery capsule with threshold release
|
|
WO2015099749A1
(en)
*
|
2013-12-27 |
2015-07-02 |
Capso Vision Inc. |
Capsule camera device with multi-spectral light sources
|
|
BR112016015140A2
(pt)
|
2013-12-30 |
2018-01-23 |
Epimab Biotherapeutics Inc. |
imunoglobulina com fabs in-tandem e usos das mesmas
|
|
GB201400442D0
(en)
*
|
2014-01-10 |
2014-02-26 |
Sigmoid Pharma Ltd |
Compositions for use in the treatment of ulcerative colitis
|
|
WO2015112575A1
(en)
|
2014-01-22 |
2015-07-30 |
The Board Of Regents Of The University Of Nebraska |
Gastrointestinal sensor implantation system
|
|
US10955422B2
(en)
*
|
2014-02-27 |
2021-03-23 |
Biogen Ma, Inc. |
Method of assessing risk of PML
|
|
DE102014004843A1
(de)
|
2014-04-02 |
2015-10-08 |
Schaltbau Gmbh |
Gleichstromschütz mit zusätzlicher Schalttauglichkeit für Wechselstromlasten und Polung entgegen der Vorzugsstromrichtung
|
|
RU2697851C2
(ru)
*
|
2014-08-13 |
2019-08-21 |
Седарс-Синаи Медикал Сентер |
Антиметаногенные композиции и их применение
|
|
EP4706525A3
(en)
*
|
2014-09-25 |
2026-04-22 |
BT Bidco, Inc. |
Electromechanical pill device with localization capabilities
|
|
US9714288B2
(en)
|
2014-09-30 |
2017-07-25 |
The Regents Of The University Of California |
Antisense compounds and uses thereof
|
|
WO2016099792A1
(en)
*
|
2014-11-19 |
2016-06-23 |
Nano Pharmaceutical Laboratories Llc |
Wireless communications system integrating electronics into orally ingestible products for controlled release of active ingredients
|
|
CN104473611B
(zh)
|
2015-01-19 |
2018-01-30 |
吉林大学 |
具有超声波定位功能的胶囊内窥镜系统
|
|
KR20170122776A
(ko)
*
|
2015-03-06 |
2017-11-06 |
신세틱 바이오로직스, 인코퍼레이티드 |
마이크로바이옴 보호를 위한 안전하고 유효한 베타-락타마제 투약
|
|
KR20240132261A
(ko)
|
2021-11-17 |
2024-09-03 |
에이치2 클리퍼, 인크. |
로봇 공학을 이용한 비행선 제작에 대한 개선된 시스템, 방법 및 장치
|